REFERENCES
[1] L. Guo, D. Wei, X. Zhang, Y. Wu, Q. Li, M. Zhou, J. Qu, Clinical
Features Predicting Mortality Risk in Patients With Viral Pneumonia: The
MuLBSTA Score, Frontiers in Microbiology 10(2752) (2019).
[2] D.M. Musher, M.S. Abers, J.G. Bartlett, Evolving Understanding
of the Causes of Pneumonia in Adults, With Special Attention to the Role
of Pneumococcus, Clinical infectious diseases : an official publication
of the Infectious Diseases Society of America 65(10) (2017) 1736-1744.
[3] F.W. Arnold, J.L. Fuqua, Viral respiratory infections: a cause
of community-acquired pneumonia or a predisposing factor?, Current
opinion in pulmonary medicine (2020).
[4] F. Zhou, T. Yu, R. Du, G. Fan, Y. Liu, Z. Liu, J. Xiang, Y.
Wang, B. Song, X. Gu, L. Guan, Y. Wei, H. Li, X. Wu, J. Xu, S. Tu, Y.
Zhang, H. Chen, B. Cao, Clinical course and risk factors for mortality
of adult inpatients with COVID-19 in Wuhan, China: a retrospective
cohort study, Lancet (London, England) (2020).
[5] R.J. Tao, X.L. Luo, W. Xu, B. Mao, R.X. Dai, C.W. Li, L. Yu, F.
Gu, S. Liang, H.W. Lu, K.B. Chen, J.W. Bai, X.B. Ji, S.Y. Gu, X.L. Sun,
F.H. Dai, P. Jiang, W.J. Cao, J.F. Xu, Viral infection in community
acquired pneumonia patients with fever: a prospective observational
study, Journal of thoracic disease 10(7) (2018) 4387-4395.
[6] J.A. McCullers, The co-pathogenesis of influenza viruses with
bacteria in the lung, Nature reviews. Microbiology 12(4) (2014) 252-62.
[7] D.M. Morens, J.K. Taubenberger, A.S. Fauci, Predominant role of
bacterial pneumonia as a cause of death in pandemic influenza:
implications for pandemic influenza preparedness, The Journal of
infectious diseases 198(7) (2008) 962-70.
[8] S.P. Jochems, F. Marcon, B.F. Carniel, M. Holloway, E. Mitsi, E.
Smith, J.F. Gritzfeld, C. Solorzano, J. Reine, S. Pojar, E. Nikolaou,
E.L. German, A. Hyder-Wright, H. Hill, C. Hales, W.A.A. de Steenhuijsen
Piters, D. Bogaert, H. Adler, S. Zaidi, V. Connor, S.B. Gordon, J.
Rylance, H.I. Nakaya, D.M. Ferreira, Inflammation induced by influenza
virus impairs human innate immune control of pneumococcus, Nature
immunology 19(12) (2018) 1299-1308.
[9] A. Rynda-Apple, K.M. Robinson, J.F. Alcorn, Influenza and
Bacterial Superinfection: Illuminating the Immunologic Mechanisms of
Disease, Infection and immunity 83(10) (2015) 3764-70.
[10] F. Zhou, H. Li, L. Gu, M. Liu, C.X. Xue, B. Cao, C. Wang, Risk
factors for nosocomial infection among hospitalised severe influenza
A(H1N1)pdm09 patients, Respiratory medicine 134 (2018) 86-91.
[11] Y.H. Ku, K.S. Chan, C.C. Yang, C.K. Tan, Y.C. Chuang, W.L. Yu,
Higher mortality of severe influenza patients with probable
aspergillosis than those with and without other coinfections, Journal of
the Formosan Medical Association = Taiwan yi zhi 116(9) (2017) 660-670.
[12] L. Xu, B. Chen, F. Wang, C. Wei, H. Liu, J. Liu, F.J.F. Herth,
F. Luo, A Higher Rate of Pulmonary Fungal Infection in Chronic
Obstructive Pulmonary Disease Patients with Influenza in a Large
Tertiary Hospital, Respiration; international review of thoracic
diseases 98(5) (2019) 391-400.
[13] P. Zou, C. Wang, S. Zheng, F. Guo, L. Yang, Y. Zhang, P. Liu,
Y. Shen, Y. Wang, X. Zhang, L. Tang, H. Gao, L. Li, Invasive Pulmonary
Aspergillosis in Adults With Avian Influenza A (H7N9) Pneumonia in
China: A Retrospective Study, The Journal of infectious diseases
221(Supplement_2) (2020) S193-s197.
[14] I. Martin-Loeches, J.S. M, J.L. Vincent, F. Alvarez-Lerma, L.D.
Bos, J. Sole-Violan, A. Torres, A. Rodriguez, Increased incidence of
co-infection in critically ill patients with influenza, Intensive care
medicine 43(1) (2017) 48-58.
[15] A.R. Falsey, K.L. Becker, A.J. Swinburne, E.S. Nylen, M.A.
Formica, P.A. Hennessey, M.M. Criddle, D.R. Peterson, A. Baran, E.E.
Walsh, Bacterial complications of respiratory tract viral illness: a
comprehensive evaluation, The Journal of infectious diseases 208(3)
(2013) 432-41.
[16] G. Abelenda-Alonso, A. Rombauts, C. Gudiol, Y. Meije, L.
Ortega, M. Clemente, C. Ardanuy, J. Niubó, J. Carratalà, Influenza and
Bacterial Coinfection in Adults With Community-Acquired Pneumonia
Admitted to Conventional Wards: Risk Factors, Clinical Features, and
Outcomes, Open forum infectious diseases 7(3) (2020) ofaa066.
[17] M.P. Crotty, S. Meyers, N. Hampton, S. Bledsoe, D.J. Ritchie,
R.S. Buller, G.A. Storch, S.T. Micek, M.H. Kollef, Epidemiology,
Co-Infections, and Outcomes of Viral Pneumonia in Adults: An
Observational Cohort Study, Medicine 94(50) (2015) e2332.
[18] F. Zhou, Y. Wang, Y. Liu, X. Liu, L. Gu, X. Zhang, Z. Pu, G.
Yang, B. Liu, Q. Nie, B. Xue, J. Feng, Q. Guo, J. Liu, H. Fan, J. Chen,
Y. Zhang, Z. Xu, M. Pang, Y. Chen, X. Nie, Z. Cai, J. Xu, K. Peng, X.
Li, P. Xiang, Z. Zhang, S. Jiang, X. Su, J. Zhang, Y. Li, X. Jin, R.
Jiang, J. Dong, Y. Song, H. Zhou, C. Wang, B. Cao, Disease severity and
clinical outcomes of community-acquired pneumonia caused by
non-influenza respiratory viruses in adults: a multicentre prospective
registry study from the CAP-China Network, The European respiratory
journal 54(2) (2019).
[19] R.P. Dellinger, M.M. Levy, A. Rhodes, D. Annane, H. Gerlach,
S.M. Opal, J.E. Sevransky, C.L. Sprung, I.S. Douglas, R. Jaeschke, T.M.
Osborn, M.E. Nunnally, S.R. Townsend, K. Reinhart, R.M. Kleinpell, D.C.
Angus, C.S. Deutschman, F.R. Machado, G.D. Rubenfeld, S. Webb, R.J.
Beale, J.L. Vincent, R. Moreno, Surviving Sepsis Campaign: international
guidelines for management of severe sepsis and septic shock, 2012,
Intensive care medicine 39(2) (2013) 165-228.
[20] K.T. Shiley, E. Lautenbach, I. Lee, The use of antimicrobial
agents after diagnosis of viral respiratory tract infections in
hospitalized adults: antibiotics or anxiolytics?, Infection control and
hospital epidemiology 31(11) (2010) 1177-83.
[21] J. Dunning, R.S. Thwaites, P.J.M. Openshaw, Seasonal and
pandemic influenza: 100 years of progress, still much to learn, Mucosal
immunology (2020) 1-8.
[22] C. Ding, Y. Zhang, Z. Yang, J. Wang, A. Jin, W. Wang, R. Chen,
S. Zhan, Incidence, temporal trend and factors associated with
ventilator-associated pneumonia in mainland China: a systematic review
and meta-analysis, BMC infectious diseases 17(1) (2017) 468.
[23] L.A. Mandell, R.G. Wunderink, A. Anzueto, J.G. Bartlett, G.D.
Campbell, N.C. Dean, S.F. Dowell, T.M. File, Jr., D.M. Musher, M.S.
Niederman, A. Torres, C.G. Whitney, Infectious Diseases Society of
America/American Thoracic Society consensus guidelines on the management
of community-acquired pneumonia in adults, Clinical infectious diseases
: an official publication of the Infectious Diseases Society of America
44 Suppl 2 (2007) S27-72.
[24] X. Li, B. Chen, S. Zhang, X. Li, J. Chang, Y. Tang, Y. Wu, X.
Lu, Rapid Detection of Respiratory Pathogens for Community-Acquired
Pneumonia by Capillary Electrophoresis-Based Multiplex PCR, SLAS
TECHNOLOGY: Translating Life Sciences Innovation 24(1) (2019) 105-116.
[25] S. Jain, W.H. Self, R.G. Wunderink, S. Fakhran, R. Balk, A.M.
Bramley, C. Reed, C.G. Grijalva, E.J. Anderson, D.M. Courtney, J.D.
Chappell, C. Qi, E.M. Hart, F. Carroll, C. Trabue, H.K. Donnelly, D.J.
Williams, Y. Zhu, S.R. Arnold, K. Ampofo, G.W. Waterer, M. Levine, S.
Lindstrom, J.M. Winchell, J.M. Katz, D. Erdman, E. Schneider, L.A.
Hicks, J.A. McCullers, A.T. Pavia, K.M. Edwards, L. Finelli,
Community-Acquired Pneumonia Requiring Hospitalization among U.S.
Adults, The New England journal of medicine 373(5) (2015) 415-27.
[26] M.P. Nicol, L. Workman, W. Isaacs, J. Munro, F. Black, B. Eley,
C.C. Boehme, W. Zemanay, H.J. Zar, Accuracy of the Xpert MTB/RIF test
for the diagnosis of pulmonary tuberculosis in children admitted to
hospital in Cape Town, South Africa: a descriptive study, The Lancet.
Infectious diseases 11(11) (2011) 819-24.
[27] J.M. Miller, M.J. Binnicker, S. Campbell, K.C. Carroll, K.C.
Chapin, P.H. Gilligan, M.D. Gonzalez, R.C. Jerris, S.C. Kehl, R. Patel,
B.S. Pritt, S.S. Richter, B. Robinson-Dunn, J.D. Schwartzman, J.W.
Snyder, S. Telford, 3rd, E.S. Theel, R.B. Thomson, Jr., M.P. Weinstein,
J.D. Yao, A Guide to Utilization of the Microbiology Laboratory for
Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases
Society of America and the American Society for Microbiology, Clinical
infectious diseases : an official publication of the Infectious Diseases
Society of America 67(6) (2018) 813-816.
[28] J.P. Donnelly, S.C. Chen, C.A. Kauffman, W.J. Steinbach, J.W.
Baddley, P.E. Verweij, C.J. Clancy, J.R. Wingard, S.R. Lockhart, A.H.
Groll, T.C. Sorrell, M. Bassetti, H. Akan, B.D. Alexander, D. Andes, E.
Azoulay, R. Bialek, R.W. Bradsher, S. Bretagne, T. Calandra, A.M.
Caliendo, E. Castagnola, M. Cruciani, M. Cuenca-Estrella, C.F. Decker,
S.R. Desai, B. Fisher, T. Harrison, C.P. Heussel, H.E. Jensen, C.C.
Kibbler, D.P. Kontoyiannis, B.J. Kullberg, K. Lagrou, F. Lamoth, T.
Lehrnbecher, J. Loeffler, O. Lortholary, J. Maertens, O. Marchetti, K.A.
Marr, H. Masur, J.F. Meis, C.O. Morrisey, M. Nucci, L.
Ostrosky-Zeichner, L. Pagano, T.F. Patterson, J.R. Perfect, Z. Racil, E.
Roilides, M. Ruhnke, C.S. Prokop, S. Shoham, M.A. Slavin, D.A. Stevens,
G.R. Thompson, J.A. Vazquez, C. Viscoli, T.J. Walsh, A. Warris, L.J.
Wheat, P.L. White, T.E. Zaoutis, P.G. Pappas, Revision and Update of the
Consensus Definitions of Invasive Fungal Disease From the European
Organization for Research and Treatment of Cancer and the Mycoses Study
Group Education and Research Consortium, Clinical infectious diseases :
an official publication of the Infectious Diseases Society of America
(2019).
[29] V.M. Ranieri, G.D. Rubenfeld, B.T. Thompson, N.D. Ferguson, E.
Caldwell, E. Fan, L. Camporota, A.S. Slutsky, Acute respiratory distress
syndrome: the Berlin Definition, Jama 307(23) (2012) 2526-33.
[30] W.S. Lim, S.V. Baudouin, R.C. George, A.T. Hill, C. Jamieson,
I. Le Jeune, J.T. Macfarlane, R.C. Read, H.J. Roberts, M.L. Levy, M.
Wani, M.A. Woodhead, BTS guidelines for the management of community
acquired pneumonia in adults: update 2009, Thorax 64 Suppl 3 (2009)
iii1-55.
[31] M.J. Fine, T.E. Auble, D.M. Yealy, B.H. Hanusa, L.A. Weissfeld,
D.E. Singer, C.M. Coley, T.J. Marrie, W.N. Kapoor, A prediction rule to
identify low-risk patients with community-acquired pneumonia, The New
England journal of medicine 336(4) (1997) 243-50.
[32] J.X. Qu, L. Gu, Z.H. Pu, X.M. Yu, Y.M. Liu, R. Li, Y.M. Wang,
B. Cao, C. Wang, Viral etiology of community-acquired pneumonia among
adolescents and adults with mild or moderate severity and its relation
to age and severity, BMC infectious diseases 15 (2015) 89.
[33] C.L. Charlton, E. Babady, C.C. Ginocchio, T.F. Hatchette, R.C.
Jerris, Y. Li, M. Loeffelholz, Y.S. McCarter, M.B. Miller, S.
Novak-Weekley, Practical guidance for clinical microbiology
laboratories: viruses causing acute respiratory tract infections,
Clinical microbiology reviews 32(1) (2018) e00042-18.
[34] Y. Zhan, Z. Yang, R. Chen, Y. Wang, W. Guan, S. Zhao,
Respiratory virus is a real pathogen in immunocompetent
community-acquired pneumonia: comparing to influenza like illness and
volunteer controls, BMC Pulm Med 14 (2014) 144.
[35] R. Gilca, R. Amini, M. Douville-Fradet, H. Charest, J. Dubuque,
N. Boulianne, D.M. Skowronski, G. De Serres, Other respiratory viruses
are important contributors to adult respiratory hospitalizations and
mortality even during peak weeks of the influenza season, Open forum
infectious diseases 1(2) (2014) ofu086.
[36] C.-C.L. a, C.-Y.W. b, P.-R.H. c, Co-infections among patients
with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2
agents?, Journal of Microbiology, Immunology and Infection (2020).
[37] I. Martin-Loeches, F. van Someren Gréve, M.J. Schultz,
Bacterial pneumonia as an influenza complication, Curr Opin Infect Dis
30(2) (2017) 201-207.
[38] R.K. Leung, J.W. Zhou, W. Guan, S.K. Li, Z.F. Yang, S.K. Tsui,
Modulation of potential respiratory pathogens by pH1N1 viral infection,
Clinical microbiology and infection : the official publication of the
European Society of Clinical Microbiology and Infectious Diseases 19(10)
(2013) 930-5.
[39] S. Edouard, M. Million, D. Bachar, G. Dubourg, C. Michelle, L.
Ninove, R. Charrel, D. Raoult, The nasopharyngeal microbiota in patients
with viral respiratory tract infections is enriched in bacterial
pathogens, European Journal of Clinical Microbiology & Infectious
Diseases 37(9) (2018) 1725-1733.
[40] T. Qin, T. Geng, H. Zhou, Y. Han, H. Ren, Z. Qiu, X. Nie, T.
Du, J. Liang, P. Du, W. Jiang, T. Li, J. Xu, Super-dominant pathobiontic
bacteria in the nasopharyngeal microbiota as causative agents of
secondary bacterial infection in influenza patients, Emerging microbes
& infections 9(1) (2020) 605-615.
[41] J.L. Vincent, Y. Sakr, M. Singer, I. Martin-Loeches, F.R.
Machado, J.C. Marshall, S. Finfer, P. Pelosi, L. Brazzi, D.
Aditianingsih, J.F. Timsit, B. Du, X. Wittebole, J. Máca, S. Kannan,
L.A. Gorordo-Delsol, J.J. De Waele, Y. Mehta, M.J.M. Bonten, A.K.
Khanna, M. Kollef, M. Human, D.C. Angus, Prevalence and Outcomes of
Infection Among Patients in Intensive Care Units in 2017, Jama (2020).
[42] J.A. Jernigan, K.M. Hatfield, H. Wolford, R.E. Nelson, B.
Olubajo, S.C. Reddy, N. McCarthy, P. Paul, L.C. McDonald, A. Kallen, A.
Fiore, M. Craig, J. Baggs, Multidrug-Resistant Bacterial Infections in
U.S. Hospitalized Patients, 2012–2017, New England Journal of Medicine
382(14) (2020) 1309-1319.
[43] M.F. Di Pasquale, G. Sotgiu, A. Gramegna, D. Radovanovic, S.
Terraneo, L.F. Reyes, J. Rupp, J. González Del Castillo, F. Blasi, S.
Aliberti, M.I. Restrepo, Prevalence and Etiology of Community-acquired
Pneumonia in Immunocompromised Patients, Clinical infectious diseases :
an official publication of the Infectious Diseases Society of America
68(9) (2019) 1482-1493.
[44] K. Sun, D.W. Metzger, Influenza Infection Suppresses NADPH
Oxidase–Dependent Phagocytic Bacterial Clearance and Enhances
Susceptibility to Secondary Methicillin-Resistant
<em>Staphylococcus
aureus</em> Infection, The Journal of Immunology
192(7) (2014) 3301-3307.
[45] G. Voiriot, B. Visseaux, J. Cohen, L.B.L. Nguyen, M. Neuville,
C. Morbieu, C. Burdet, A. Radjou, F.-X. Lescure, R. Smonig, L.
Armand-Lefèvre, B. Mourvillier, Y. Yazdanpanah, J.-F. Soubirou, S.
Ruckly, N. Houhou-Fidouh, J.-F. Timsit, Viral-bacterial coinfection
affects the presentation and alters the prognosis of severe
community-acquired pneumonia, Critical Care 20(1) (2016) 375.
[46] L.O. Bakaletz, Viral-bacterial co-infections in the respiratory
tract, Current opinion in microbiology 35 (2017) 30-35.
[47] B.S. Bender, T. Croghan, L. Zhang, P.A. Small, Jr, Transgenic
mice lacking class I major histocompatibility complex-restricted T cells
have delayed viral clearance and increased mortality after influenza
virus challenge, Journal of Experimental Medicine 175(4) (1992)
1143-1145.
[48] R.M. Koch, M. Kox, M.I. de Jonge, J.G. van der Hoeven, G.
Ferwerda, P. Pickkers, Patterns in Bacterial- and Viral-Induced
Immunosuppression and Secondary Infections in the ICU, Shock (Augusta,
Ga.) 47(1) (2017) 5-12.
[49] R. Pfister, M. Kochanek, T. Leygeber, C. Brun-Buisson, E.
Cuquemelle, M.B. Machado, E. Piacentini, N.E. Hammond, P.R. Ingram, G.
Michels, Procalcitonin for diagnosis of bacterial pneumonia in
critically ill patients during 2009 H1N1 influenza pandemic: a
prospective cohort study, systematic review and individual patient data
meta-analysis, Critical care (London, England) 18(2) (2014) R44.
[50] C.-E. Luyt, T.W. Rice, Co-infection in severe influenza: a new
epidemiology?, Intensive care medicine 43(1) (2017) 107-109.
[51] A.M. Walker, H. Jick, J. Porter, Drug-Related Superinfection in
Hospitalized Patients, Jama 242(12) (1979) 1273-1275.
[52] K. Chen, J.K. Kolls, T cell-mediated host immune defenses in
the lung, Annual review of immunology 31 (2013) 605-33.
[53] L.J. Quinton, A.J. Walkey, J.P. Mizgerd, Integrative Physiology
of Pneumonia, Physiological reviews 98(3) (2018) 1417-1464.